Urology
Volume 72, Issue 6 , Pages 1219-1223 , December 2008

Does Laterality of Positive Needle Biopsy in Clinical T2a Patients With Prostate Cancer Affect Biochemical Recurrence-Free Survival?

Received 26 August 2007 ,Accepted 21 December 2007.

References 

  1. American Cancer Society. Cancer Facts and Figures 2007. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdfAccessed Mar 9, 2008
  2. National Cancer Institute. Prostate cancer treatment: stage information. http://www.cancer.gov/cancertopics/pdq/treatment/prostate/Patient/page2Accessed Mar 9, 2008
  3. Mouraviev V, Mayes JM, Sun L, et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer. 2007;110:906–910
  4. Vis AN, Kranse R, Roobol M, et al. Serendipity in detecting disease in low prostate-specific antigen ranges. BJU Int. 2002;89:384–389
  5. Ghavamian R, Blute ML, Bergstralh EJ, et al. Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology. 1999;54:105–110
  6. Ramos CG, Carvalhal GF, Smith DS, et al. Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer. J Urol. 1999;161:1525–1529
  7. Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90:766–771
  8. Daniels GF, McNeal JE, Stamey TA. Predictive value of contralateral biopsies in unilaterally palpable prostate cancer. J Urol. 1992;147:870–874
  9. Freedland SJ, Presti JC, Terris MK, et al. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. J Urol. 2003;169:2129–2135
  10. Campbell T, Blasko J, Crawford ED, et al. Clinical staging of prostate cancer: reproducibility and clarification of issues. Int J Cancer. 2001;96:198–209
  11. Sexton T, Rodrigues G, Brecevic E, et al. Controversies in prostate cancer staging implementation at a tertiary cancer center. Can J Urol. 2006;13:3327–3334

PII: S0090-4295(07)02685-4

doi: 10.1016/j.urology.2007.12.089

Urology
Volume 72, Issue 6 , Pages 1219-1223 , December 2008

Article Tools

* Image Usage & Resolution